LobbyingTranslational Genomics Research Institute lobbying by quarter
Translational Genomics Research Institute's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.
Translational Genomics Research Institute
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $10K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$70K · 9 reports
- Medical research and clinical labs$30K · 5 reports
- Health issues$10K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE11 reports
Firms it paid
| Firm | ||
|---|---|---|
| First Strategic | $150K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/13for Q2 | First Strategic | $10K |
| 04/30for Q1 | First Strategic | $10K |
| 01/07for Q4 2025 | First Strategic | $10K |
| 25/10/23for Q3 2025 | First Strategic | $10K |
| 25/07/22for Q2 2025 | First Strategic | $10K |
| 25/04/30for Q1 2025 | First Strategic | $10K |
| 25/02/04for Q4 2024 | First Strategic | $10K |
| 24/10/24for Q3 2024 | First Strategic | $10K |
| 24/07/22for Q2 2024 | First Strategic | $10K |
| 24/05/02for Q1 2024 | First Strategic | $10K |
| 24/01/29for Q4 2023 | First Strategic | $10K |
| 23/11/15for Q3 2023 | First Strategic | $10K |
| 23/07/12for Q2 2023 | First Strategic | $10K |
| 23/04/17for Q1 2023 | First Strategic | $10K |
| 23/01/16for Q4 2022 | First Strategic | $10K |